Pharmaceutical Preparations · DE · CIK 1070494
Develops and commercializes treatments for neurological and rare diseases, including Parkinson's disease psychosis and Rett syndrome
Comparable business profile · signals at a glance
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 26, 2026: 5 sold $770K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Sell | 3,171 | $21.65 | $69K |
| Mar 26, 2026 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | Sell | 1,097 | $21.65 | $24K |
| Mar 26, 2026 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Sell | 37 | $21.72 | $804 |
| Mar 26, 2026 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | Sell | 12 | $21.73 | $261 |
| Mar 25, 2026 | Owen Adams CatherineChief Executive Officer | Sell | 11,641 | $21.47 | $250K |
| Mar 25, 2026 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Sell | 4,177 | $21.47 | $90K |
| Mar 25, 2026 | Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC | Sell | 3,844 | $21.47 | $83K |
| Mar 25, 2026 | Thompson Elizabeth H.Z.EVP, Head of Research & Dev | Sell | 3,435 | $21.47 | $74K |
| Mar 25, 2026 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | Sell | 833 | $21.47 | $18K |
| Feb 9, 2026 | Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC | Sell | 6,950 | $23.38 | $162K |
| Nov 18, 2025 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Sell | 10,262 | $23.69 | $243K |
| Nov 18, 2025 | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | Sell | 4,084 | $23.69 | $97K |
| Nov 10, 2025 | Daly James MDirector | Sell | 30,000 | $22.37 | $671K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.